ENCell Co., Ltd. is a South Korean biotechnology company and CDMO specializing in cell and gene therapy, founded in 2018 as a spin-off from Samsung Medical Center. The company operates three separate GMP facilities and provides end-to-end pharmaceutical development services from R&D to regulatory approval, including drug substance/product manufacturing and contract quality testing.
Cell & gene therapy CDMO, Viral vector production, GMP manufacturing, CMC consulting, IND filing support
1 site worldwide
Involvement in 1 clinical trial
No certifications on file yet.
No reviews available yet.
No documents available.